AI Guardian for Parkinson's Taps World's Largest Wearable Dataset

SAN FRANCISCO, CA – April 08, 2026 – Rune Labs today announced the launch of StrivePD Guardian, a personalized AI companion designed to provide continuous, data-driven support for people living with Parkinson’s disease. The new tool, powered by Anthropic's advanced Claude AI model, leverages what the company calls the world's largest longitudinal dataset of Parkinson's symptoms to offer real-time guidance and insights directly to patients.

The launch represents a significant step forward in the application of artificial intelligence to chronic disease management. By analyzing a constant stream of data from wearables like the Apple Watch, StrivePD Guardian aims to demystify the fluctuating symptoms of Parkinson's, empowering patients to better manage their condition between infrequent clinical visits.

“People with Parkinson’s live with symptoms that change hour-to-hour,” said Amy Franzen, CEO of Rune Labs, in the announcement. “StrivePD Guardian provides support in those moments, translating continuous symptom changes into clearer understanding, better management, and more productive clinical visits.”

A New Generation of AI-Powered Neurology

At the core of StrivePD Guardian is a sophisticated technological architecture. The system is built upon Rune Labs' proprietary dataset, which includes over 4.5 million patient-days of data collected via the StrivePD platform. This vast repository, focused on real-world, continuous data from consumer wearables, is a key differentiator in a field where large-scale research often relies on patient-reported outcomes or data from clinical trials.

The AI engine driving the companion is a customized version of Anthropic's Claude 3.5 Sonnet, a leading large language model. Rune Labs has fine-tuned the generic model, embedding it with deep knowledge of Parkinson's disease and a set of proprietary clinical "guide rails." This specialization allows the AI to interpret complex physiological patterns with a nuance that general-purpose AI cannot match.

“Because StrivePD Guardian is trained on our continuous wearable datasets, it can interpret 'off times' and dyskinesia with a level of precision that general-purpose AI models simply cannot achieve,” explained William Newby, Vice President of Product and Strategy at Rune Labs. “We’re connecting abstract symptoms with objective physiological patterns.”

Unlike a single, monolithic AI, StrivePD Guardian operates as an "agentic system." When a user asks a question, the query is automatically routed to one of several specialized sub-agents, including a Medication Assistant for drug information, a Symptom Expert for interpreting data trends, a PD Coach for habit formation, and a Journal Companion for tracking emotional and symptomatic experiences. This ensures responses are not only relevant but also drawn from curated, medical-grade content.

Empowering Patients and Bridging Care Gaps

For individuals navigating the daily challenges of Parkinson's, the platform promises a new level of autonomy and insight. The system synthesizes raw wearable data on metrics like tremor and dyskinesia—symptoms for which Rune Labs has FDA clearance to monitor via Apple Watch—with patient-logged information on medication, diet, and mood.

The result is a dynamic, personalized feedback loop. One user, Kevin K., described the experience in the company's press release: “It’s like having a conversation with my own StrivePD data. The monthly AI reports help me step back and see the bigger picture, and the StrivePD Guardian chat helps me day to day. I can ask questions, get quick answers, all grounded in what I’ve logged.”

This empowerment is translating into tangible clinical benefits. A 2024 validation study of the broader StrivePD program, which now incorporates the Guardian AI, reported impressive outcomes, including a nearly 50% reduction in emergency room visits. The study also found that 90% of patients increased their exercise and 80% improved their medication adherence, two critical factors in managing Parkinson's progression.

Neurologists see significant potential in tools that can fill the long gaps between appointments. "A service like this could provide crucial ongoing support, leading to better patient outcomes and a more proactive approach to managing the disease," noted one neurology specialist familiar with digital health tools. Another clinician at a major health system commented that the platform provides a "much richer understanding" of his patients' disease progression, enabling more confident management.

Navigating the Regulatory and Clinical Frontier

Integrating a sophisticated AI directly into patient care pathways requires a delicate balance of innovation and safety. Rune Labs has built StrivePD Guardian with this challenge in mind, emphasizing its development under strict clinical oversight. The platform's data collection capabilities are built on the foundation of its 2022 FDA 510(k) clearance for the StrivePD app to measure tremor and dyskinesia using an Apple Watch.

The AI companion itself includes carefully designed safety "guardrails." It uses cautious, supportive language and is programmed to recognize signs of urgent issues, prompting users to contact their doctor or seek emergency care when necessary. These safeguards are designed to ensure the tool operates as a supportive aid within established clinical frameworks, rather than a replacement for professional medical advice.

This approach is crucial for gaining the trust of both clinicians and healthcare systems. By providing physicians with curated dashboards and personalized symptom summaries, the platform can enhance the efficiency of clinical visits and help mitigate the growing shortage of movement disorder specialists.

A Competitive Edge in a Growing Market

While other digital tools exist for Parkinson's management, such as the FDA-cleared PKG™ system that also monitors motor symptoms, Rune Labs is positioning StrivePD Guardian as a uniquely comprehensive solution. Its key differentiators lie in the immense scale of its real-world wearable dataset, the integration of a top-tier generative AI model, and its FDA-cleared functionality on a widely used consumer device, which helps reduce the stigma associated with wearing a dedicated medical device.

Despite significant interest, a 2024 survey showed that only a fraction of Parkinson's patients currently use wearables for disease management. This highlights a substantial opportunity for user-friendly and clinically validated tools to gain traction. By demonstrating clear improvements in patient adherence and reductions in acute care needs, Rune Labs is making a strong case for its platform's value to patients, providers, and payers alike.

StrivePD Guardian is now available to the public through the Apple App Store, with existing StrivePD users able to upgrade within the app. Rune Labs is also making the platform available through partner programs with healthcare providers to support ongoing patient monitoring, engagement, and care coordination efforts across health systems.